← Leaderboards
Rima F Kaddurah-Daouk
Duke University
$56,438,861
Attributed
$81,038,015
Total exposure
28
Grants
27
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $16.6M · FY2007–25$20M$15M$10M$5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$112,895,836 · 29
By mechanism
U19$61,290,697 · 13
RF1$19,105,567 · 4
U01$14,979,704 · 3
R01$10,805,164 · 5
RC2$4,507,931 · 1
R24$2,196,273 · 2
Top collaborators
- Gabi Kastenmuller10 shared
- Cornelia Marja Van Duijn8 shared
- Robin Knight6 shared
- Sarkis K Mazmanian6 shared
- Matthias Arnold5 shared
- Oliver Fiehn5 shared
- Lee E Goldstein5 shared
- Peter John Meikle5 shared
Most similar at Duke University
Same institution · by research overlap
- Uptal D Patel$4,543,116
- Mitchel Allan Kling$3,150,208
- Matthew O Fraser$1,053,434
- David Brady$187,112
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposMetabolomicsS DiseaseSamplingMetabolicBrainPathogenesisLinkCommunitiesMolecularPhenotypeGeneticInsightPeripheralBiochemicalGut MicrobiomeCohortBiological MarkersMetabolismImpaired CognitionPlayMedicineBaseBiochemical Pathway
Grant awards (85)
The Role of Chemical Exposures in Alzheimer's Disease (AD) and its Trajectory$2,107,225
U01 · FY2025 · AG · contact PI
Metabolic age to define influences of the lipidome on brain aging in Alzheimer's disease$447,444
R01 · FY2025 · AG · contact PI
The Role of Chemical Exposures in Alzheimer's Disease (AD) and its Trajectory$79,380
U01 · FY2025 · AG · contact PI
Metabolic age to define influences of the lipidome on brain aging in Alzheimer's disease$74,088
R01 · FY2025 · AG · contact PI
Metabolic age to define influences of the lipidome on brain aging in Alzheimer's disease$74,088
R01 · FY2025 · AG · contact PI
The Role of Chemical Exposures in Alzheimer's Disease (AD) and its Trajectory$55,842
U01 · FY2025 · AG · contact PI
The Role of Chemical Exposures in Alzheimer's Disease (AD) and its Trajectory$26,460
U01 · FY2025 · AG · contact PI
The Role of Chemical Exposures in Alzheimer's Disease (AD) and its Trajectory$2,499,382
U01 · FY2024 · AG · contact PI
Metabolic age to define influences of the lipidome on brain aging in Alzheimer's disease$667,269
R01 · FY2024 · AG · contact PI
Alzheimer's Gut Microbiome Project$7,690,237
U19 · FY2023 · AG · contact PI
Administrative Core$2,115,278
U19 · FY2023 · AG · contact PI
Omics and Technology Core$2,082,811
U19 · FY2023 · AG · contact PI
Project 1 - Changes in Gut Microbiome and related Metabolome Across Trajectory of Alzheimer's Disease$959,860
U19 · FY2023 · AG · contact PI
Project 2 - Influence of controlled diets on gut microbiome, metabolome and cognitive function$901,752
U19 · FY2023 · AG · contact PI
Project 3 - Mechanistic studies on role of gut microbiome in models for Alzheimer's disease$829,047
U19 · FY2023 · AG · contact PI
Computational and Systems Biology Core$801,489
U19 · FY2023 · AG · contact PI
Metabolic age to define influences of the lipidome on brain aging in Alzheimer's disease$725,129
R01 · FY2023 · AG · contact PI
Alzheimer's Gut Microbiome Project$5,306,873
U19 · FY2022 · AG · contact PI
Data Infrastructure and Molecular Atlas for Alzheimer's Disease: Connecting Exposome, Gut Microbiome, and Metabolome.$2,424,945
U19 · FY2022 · AG · contact PI
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD$1,928,443
U01 · FY2022 · AG · contact PI
Administrative Core$1,718,108
U19 · FY2022 · AG · contact PI
Omics and Technology Core$1,685,666
U19 · FY2022 · AG · contact PI
Characterizing the AD Metabolome in Brain Tissue Samples of Individuals from Diverse Populations$1,255,605
U01 · FY2022 · AG · contact PI
Project 1 - Changes in Gut Microbiome and related Metabolome Across Trajectory of Alzheimer's Disease$563,952
U19 · FY2022 · AG · contact PI
Project 2 - Influence of controlled diets on gut microbiome, metabolome and cognitive function$502,911
U19 · FY2022 · AG · contact PI
Project 3 - Mechanistic studies on role of gut microbiome in models for Alzheimer's disease$430,206
U19 · FY2022 · AG · contact PI
Computational and Systems Biology Core$406,030
U19 · FY2022 · AG · contact PI
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD$346,752
U01 · FY2022 · AG · contact PI
Alzheimer's Gut Microbiome Project$5,321,511
U19 · FY2021 · AG · contact PI
Administrative Core$1,725,753
U19 · FY2021 · AG · contact PI
Omics and Technology Core$1,686,651
U19 · FY2021 · AG · contact PI
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD$1,619,858
U01 · FY2021 · AG · contact PI
Project 1 - Changes in Gut Microbiome and related Metabolome Across Trajectory of Alzheimer's Disease$566,446
U19 · FY2021 · AG · contact PI
Project 2 - Influence of controlled diets on gut microbiome, metabolome and cognitive function$502,911
U19 · FY2021 · AG · contact PI
Project 3 - Mechanistic studies on role of gut microbiome in models for Alzheimer's disease$430,206
U19 · FY2021 · AG · contact PI
Computational and Systems Biology Core$409,544
U19 · FY2021 · AG · contact PI
Alzheimer's Gut Microbiome Project$5,424,083
U19 · FY2020 · AG · contact PI
Administrative Core$1,832,612
U19 · FY2020 · AG · contact PI
Omics and Technology Core$1,682,205
U19 · FY2020 · AG · contact PI
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD$1,604,844
U01 · FY2020 · AG · contact PI
Project 1 - Changes in Gut Microbiome and related Metabolome Across Trajectory of Alzheimer's Disease$563,038
U19 · FY2020 · AG · contact PI
Project 2 - Influence of controlled diets on gut microbiome, metabolome and cognitive function$502,911
U19 · FY2020 · AG · contact PI
Project 3 - Mechanistic studies on role of gut microbiome in models for Alzheimer's disease$430,206
U19 · FY2020 · AG · contact PI
Computational and Systems Biology Core$413,111
U19 · FY2020 · AG · contact PI
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD$125,041
U01 · FY2020 · AG · contact PI
Alzheimer's Gut Microbiome Project$5,690,172
U19 · FY2019 · AG · contact PI
Administrative Core$1,865,582
U19 · FY2019 · AG · contact PI
Omics and Technology Core$1,755,916
U19 · FY2019 · AG · contact PI
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD$1,501,317
U01 · FY2019 · AG · contact PI
Metabolomic Signatures Predictive of Outcomes to Treatments for Major Depression$642,447
R01 · FY2019 · MH · contact PI
Project 1 - Changes in Gut Microbiome and related Metabolome Across Trajectory of Alzheimer's Disease$595,839
U19 · FY2019 · AG · contact PI
Project 2 - Influence of controlled diets on gut microbiome, metabolome and cognitive function$564,662
U19 · FY2019 · AG · contact PI
Computational and Systems Biology Core$462,717
U19 · FY2019 · AG · contact PI
Project 3 - Mechanistic studies on role of gut microbiome in models for Alzheimer's disease$445,456
U19 · FY2019 · AG · contact PI
Metabolic Networks and Pathways Predictive of Sex Differences in AD Risk and Responsiveness to Treatment$5,887,658
RF1 · FY2018 · AG · contact PI
Gut Liver Brain Biochemical Axis in Alzheimer's Disease$3,407,970
RF1 · FY2018 · AG · contact PI
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD$1,659,230
U01 · FY2018 · AG · contact PI
Metabolomic Signatures Predictive of Outcomes to Treatments for Major Depression$670,790
R01 · FY2018 · MH · contact PI
Metabolic Network Analysis of Biochemical Trajectories in Alzheimer's Disease$3,509,523
RF1 · FY2017 · AG · contact PI
Metabolomic Signatures Predictive of Outcomes to Treatments for Major Depression$660,172
R01 · FY2017 · MH · contact PI
Metabolic Networks and Pathways in Alzheimer's Disease$186,850
R01 · FY2017 · AG · contact PI
Metabolic Networks and Pathways in Alzheimer's Disease$1,544,530
R01 · FY2016 · AG · contact PI
Metabolomic Signatures Predictive of Outcomes to Treatments for Major Depression$759,676
R01 · FY2016 · MH · contact PI
Metabolic Networks and Pathways in Alzheimer's Disease$628,287
R01 · FY2016 · AG · contact PI
Metabolic Signatures Underlying Vascular Risk Factors for Alzheimer-type Dementias$498,020
RF1 · FY2016 · AG · contact PI
Metabolic Signatures Underlying Vascular Risk Factors for Alzheimer-type Dementias$5,802,396
RF1 · FY2015 · AG · contact PI
Metabolic Networks and Pathways in Alzheimer's Disease$957,041
R01 · FY2015 · AG · contact PI
Metabolic Networks and Pathways in Alzheimer's Disease$111,434
R01 · FY2015 · AG · contact PI
Metabolic Networks and Pathways in Alzheimer's Disease$974,544
R01 · FY2014 · AG · contact PI
ADNI Duke Supplement$170,325
U01 · FY2014 · AG
Metabolomics 2012$10,500
R13 · FY2012 · GM · contact PI
Metabolomic Signatures and Biomarkers for Schizophrenia$371,044
R01 · FY2011 · MH · contact PI
Metabolomics Network for Drug Response Phenotype$2,211,244
RC2 · FY2010 · GM · contact PI
Metabolomics Network for Drug Response Phenotype$502,059
R24 · FY2010 · GM · contact PI
Metabolomic Signatures and Biomarkers for Schizophrenia$389,309
R01 · FY2010 · MH · contact PI
Pharmacometabolomics Research Network$78,000
R24 · FY2010 · GM · contact PI
Metabolomics Network for Drug Response Phenotype$2,296,687
RC2 · FY2009 · GM · contact PI
Metabolomics Network for Drug Response Phenotype$468,125
R24 · FY2009 · GM · contact PI
Metabolic Signatures for Alzheimer's Disease$266,220
R01 · FY2009 · NS · contact PI
Metabolic Signatures for Alzheimer's Disease$78,000
R01 · FY2009 · NS · contact PI
Metabolomics Network for Drug Response Phenotype$496,192
R24 · FY2008 · GM · contact PI
Metabolic Signatures for Alzheimer's Disease$267,630
R01 · FY2008 · NS · contact PI
Metabolomics Network for Drug Response Phenotype$573,897
R24 · FY2007 · GM · contact PI
Metabolic Signatures for Alzheimer's Disease$309,172
R01 · FY2007 · NS · contact PI
Metabolomics Network for Drug Response Phenotype$78,000
R24 · FY2007 · GM · contact PI